Ticker Details
AtriCure, Inc. AtriCure Inc is a medical device company. It develops, manufactures and sells cardiac surgical ablation systems designed to create precise lesions, scars in cardiac, heart, and tissue. It generates revenue by selling disposable surgical devices.
IPO Date:	August 5, 2005
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$1.43B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.46 | 2.12%
Avg Daily Range (30 D):	$0.53 | 1.87%
Avg Daily Range (90 D):	$0.60 | 1.88%

Institutional Daily Volume
Avg Daily Volume:	.18M
Avg Daily Volume (30 D):	.66M
Avg Daily Volume (90 D):	.57M

Trade Size
Avg Trade Size (Sh.):	70
Avg Trade Size (Sh.) (30 D):	54
Avg Trade Size (Sh.) (90 D):	53

Institutional Trades
Total Institutional Trades:	3,474
Avg Institutional Trade:	$1.83M
Avg Institutional Trade (30 D):	$2.67M
Avg Institutional Trade (90 D):	$2.37M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.12M
Avg Closing Trade (30 D):	$3.78M
Avg Closing Trade (90 D):	$3.42M
Avg Closing Volume:	56.22K

News

Nov 29, 2025 @ 9:24 PM Is AtriCure Stock a Buy or Sell After a Director D... Source: Robert Izquierdo

May 14, 2025 @ 6:00 PM Questex’s Fierce Healthcare Announces 2025 ... Source: Questex'S Fierce Healthcare

Jul 23, 2024 @ 6:08 PM AtriCure gains China's nod for heart surgery devic... Source: Natashya Angelica

May 2, 2024 @ 12:01 PM Cracking The Code: Understanding Analyst Reviews F... Source: Benzinga Insights

May 2, 2024 @ 12:00 AM Compared to Estimates, AtriCure (ATRC) Q1 Earnings... Source: Zacks Equity Research

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.1	$	$.04
Diluted EPS	$-.1	$	$.04
Revenue	$552.16M	$141.25M	$140.5M
Gross Profit	$417.46M	$109.31M	$105.34M
Net Income / Loss	$-4.59M	$.11M	$1.76M
Operating Income / Loss	$-2.97M	$.53M	$2.49M
Cost of Revenue	$134.7M	$31.94M	$35.16M
Net Cash Flow	$46.28M	$-21.26M	$19.56M
PE Ratio